Spots Global Cancer Trial Database for differentiated thyroid carcinoma
Every month we try and update this database with for differentiated thyroid carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma | NCT00148213 | Thyroid Neoplas... | 0 Years - | University Hospital Muenster | ||
| Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy | NCT00104871 | Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... | Bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. | NCT03845647 | Lymph Node Diss... Lymph Node Meta... Differentiated ... | contralateral c... | 18 Years - 65 Years | Fifth Affiliated Hospital, Sun Yat-Sen University | |
| Post-Marketing Surveillance of Lenvima in Korean Patients | NCT02764554 | Differentiated ... | - | Eisai Inc. | ||
| Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma | NCT00148213 | Thyroid Neoplas... | 0 Years - | University Hospital Muenster | ||
| OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation | NCT00439127 | Differentiated ... | - | Oncology Institute of Southern Switzerland | ||
| Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy | NCT00104871 | Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... | Bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer | NCT06359847 | Differentiated ... | ST-1898 tablets | 18 Years - | Beijing Scitech-Mq Pharmaceuticals Limited | |
| Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients | NCT03776123 | Renal Cell Carc... Hepatocellular ... Differentiated ... | 18 Years - | Ipsen | ||
| Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma | NCT05078853 | Differentiated ... Lymph Node Meta... | Point of care a... | 18 Years - 120 Years | Soroka University Medical Center | |
| Pembrolizumab in High-risk Thyroid Cancer | NCT05852223 | Differentiated ... | Pembrolizumab | 18 Years - | Istituti Clinici Scientifici Maugeri SpA | |
| Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma | NCT03167385 | Differentiated ... | Apatinib Mesyla... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Multicenter Study Differentiated Thyroid Carcinoma | NCT00144079 | Thyroid Neoplas... | external beam r... | 18 Years - 69 Years | University Hospital Muenster |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
